Susquehanna International Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,200
| Closed | -$136K | – | 12920 |
|
|
2024
Q4 | $136K | Buy |
22,200
+7,000
| +46% | +$83.2K | ﹤0.01% | 11093 |
|
|
2024
Q3 | $251K | Buy |
+15,200
| New | +$167K | ﹤0.01% | 9995 |
|
|
2024
Q1 | – | Sell |
-10,700
| Closed | -$88.9K | – | 12693 |
|
|
2023
Q4 | $88.9K | Buy |
+10,700
| New | +$62.1K | ﹤0.01% | 11412 |
|
|
2023
Q2 | – | Sell |
-22,100
| Closed | -$304K | – | 12555 |
|
|
2023
Q1 | $304K | Buy |
+22,100
| New | +$457K | ﹤0.01% | 9690 |
|
|
2022
Q4 | – | Sell |
-13,900
| Closed | -$316K | – | 12983 |
|
|
2022
Q3 | $316K | Sell |
13,900
-44,000
| -76% | -$888K | ﹤0.01% | 9668 |
|
|
2022
Q2 | $1.04M | Sell |
57,900
-43,500
| -43% | -$775K | ﹤0.01% | 6435 |
|
|
2022
Q1 | $2.71M | Buy |
101,400
+77,900
| +331% | +$1.45M | ﹤0.01% | 4815 |
|
|
2021
Q4 | $689K | Buy |
23,500
+7,700
| +49% | +$383K | ﹤0.01% | 8306 |
|
|
2021
Q3 | $1.04M | Buy |
15,800
+7,400
| +88% | +$566K | ﹤0.01% | 7460 |
|
|
2021
Q2 | $699K | Sell |
8,400
-10,800
| -56% | -$800K | ﹤0.01% | 8743 |
|
|
2021
Q1 | $1.47M | Sell |
19,200
-5,600
| -23% | -$510K | ﹤0.01% | 6685 |
|
|
2020
Q4 | $2.19M | Sell |
24,800
-135,300
| -85% | -$9.51M | ﹤0.01% | 4905 |
|
|
2020
Q3 | $11.8M | Buy |
+160,100
| New | +$9.48M | ﹤0.01% | 1992 |
|
Other funds holding IGMS
Susquehanna International Group's IGMS Position: Q3 2025 in Review
Susquehanna International Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 80,311 shares — an estimated $89.9K sold.
Susquehanna International Group first reported a position in IGMS in Q3 2020 and held it in 13 quarters. The position peaked at $2.17M in Q3 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Susquehanna International Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 80,311 IGM Biosciences shares in Q3 2025, an estimated $89.9K.
- Susquehanna International Group first reported a position in IGM Biosciences in Q3 2020 and held it in 13 quarters.
- Susquehanna International Group's IGM Biosciences position peaked at $2.17M in Q3 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.